FR16C0029I1 - - Google Patents

Info

Publication number: FR16C0029I1
Authority: FR; France
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Active

Application number

Other languages

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2004-04-22

Filing date

2016-06-22

Publication date

2016-08-26

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=34966478&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=FR16C0029(I1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

2004-04-22 Priority claimed from DE102004019540A external-priority patent/DE102004019540A1/en

2004-11-03 Priority claimed from DE102004052987A external-priority patent/DE102004052987A1/en

2016-06-22 Application filed filed Critical

2016-08-26 Publication of FR16C0029I1 publication Critical patent/FR16C0029I1/fr

2017-01-27 Application granted granted Critical

2017-01-27 Publication of FR16C0029I2 publication Critical patent/FR16C0029I2/en

Status Active legal-status Critical Current

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
- A61K31/5375—1,4-Oxazines, e.g. morpholine
- A61K31/538—1,4-Oxazines, e.g. morpholine ortho- or peri-condensed with carbocyclic ring systems
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/06—Antiabortive agents; Labour repressants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
- A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
- A61P33/10—Anthelmintics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/06—Antiarrhythmics

Landscapes

Health & Medical Sciences (AREA)
Veterinary Medicine (AREA)
Life Sciences & Earth Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Animal Behavior & Ethology (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Organic Chemistry (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
Immunology (AREA)
Epidemiology (AREA)
Pulmonology (AREA)
Cardiology (AREA)
Communicable Diseases (AREA)
Oncology (AREA)
Tropical Medicine & Parasitology (AREA)
Heart & Thoracic Surgery (AREA)
Virology (AREA)
Dermatology (AREA)
Pain & Pain Management (AREA)
Gynecology & Obstetrics (AREA)
Pregnancy & Childbirth (AREA)
Endocrinology (AREA)
Reproductive Health (AREA)
Rheumatology (AREA)
Transplantation (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Medicinal Preparation (AREA)
Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

FR16C0029C 2004-04-22 2016-06-22 DRUG COMBINATIONS CONTAINING BENZOXAZINE FOR THE TREATMENT OF RESPIRATORY TRACT DISEASES Active FR16C0029I2 (en)

Applications Claiming Priority (5)

Application Number	Priority Date	Filing Date	Title
DE102004019540A DE102004019540A1 (en)	2004-04-22	2004-04-22	Composition, useful for treatment of e.g. inflammatory and obstructive respiratory complaint, sinus rhythm in heart in atrioventricular block and circulatory shock, comprises 6-hydroxy-4H-benzo1,4oxazin-3-one derivatives and other actives
DE102004052987A DE102004052987A1 (en)	2004-11-03	2004-11-03	Composition, useful for treatment of e.g. inflammatory and obstructive respiratory complaint, sinus rhythm in heart in atrioventricular block and circulatory shock, comprises 6-hydroxy-4H-benzo1,4oxazin-3-one derivatives and other actives
EP05002496		2005-02-07
PCT/EP2005/004073 WO2005102349A1 (en)	2004-04-22	2005-04-18	Pharmaceutical combinations containing benzoxazine for treating respiratory diseases
EP05739576A EP1781298B1 (en)	2004-04-22	2005-04-18	Pharmaceutical combinations containing benzoxazine for treating respiratory diseases

Publications (2)

Publication Number	Publication Date
FR16C0029I1 true FR16C0029I1 (en)	2016-08-26
FR16C0029I2 FR16C0029I2 (en)	2017-01-27

Family

ID=34966478

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
FR16C0029C Active FR16C0029I2 (en)	2004-04-22	2016-06-22	DRUG COMBINATIONS CONTAINING BENZOXAZINE FOR THE TREATMENT OF RESPIRATORY TRACT DISEASES

Country Status (33)

Country	Link
EP (2)	EP1781298B1 (en)
JP (1)	JP2007533683A (en)
KR (2)	KR20130049840A (en)
AR (1)	AR049262A1 (en)
AT (1)	ATE539754T1 (en)
AU (1)	AU2005235419B2 (en)
BE (1)	BE2015C065I2 (en)
BR (1)	BRPI0510080B8 (en)
CA (1)	CA2559699C (en)
CY (3)	CY1113890T1 (en)
DK (2)	DK2422786T3 (en)
EA (1)	EA013157B1 (en)
EC (1)	ECSP066947A (en)
ES (2)	ES2523518T3 (en)
FI (1)	FIC20170005I1 (en)
FR (1)	FR16C0029I2 (en)
HU (1)	HUS1500058I1 (en)
IL (2)	IL177685A (en)
LT (1)	LTC1781298I2 (en)
LU (1)	LU93066I2 (en)
MY (1)	MY148945A (en)
NL (1)	NL300779I2 (en)
NO (2)	NO337714B1 (en)
NZ (1)	NZ550797A (en)
PE (1)	PE20060462A1 (en)
PL (2)	PL2422786T3 (en)
PT (2)	PT1781298E (en)
SG (1)	SG152237A1 (en)
SI (2)	SI2422786T1 (en)
TW (2)	TWI374739B (en)
UY (1)	UY28861A1 (en)
WO (1)	WO2005102349A1 (en)
ZA (1)	ZA200606624B (en)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US7056916B2 (en)	2002-11-15	2006-06-06	Boehringer Ingelheim Pharma Gmbh & Co. Kg	Medicaments for the treatment of chronic obstructive pulmonary disease
DE102004024452A1 (en) *	2004-05-14	2005-12-08	Boehringer Ingelheim Pharma Gmbh & Co. Kg	Aerosol formulation for the inhalation of beta agonists
US7220742B2 (en)	2004-05-14	2007-05-22	Boehringer Ingelheim International Gmbh	Enantiomerically pure beta agonists, process for the manufacture thereof and use thereof as medicaments
US7923455B2 (en) *	2005-01-28	2011-04-12	Boehringer Ingelheim International Gmbh	Medicaments for the prevention or treatment of heart failure comprising administration of an anticholinergic
CA2597942A1 (en) *	2005-02-16	2006-08-24	Boehringer Ingelheim International Gmbh	Pharmaceutical compositions comprising anticholinergics and etiprednol
EP1917253B1 (en)	2005-08-15	2015-01-07	Boehringer Ingelheim International Gmbh	Method for producing betamimetics
TWI389692B (en) *	2005-10-10	2013-03-21	Boehringer Ingelheim Int	Aerosol formulations for the inhalation of beta-agonists
TWI396541B (en)	2005-10-10	2013-05-21	Boehringer Ingelheim Int	Novel combinations of medicaments for the treatment of respiratory diseases
CA2627982C (en) *	2005-11-10	2013-09-10	Nicholas S. Bodor	Soft anticholinergic esters
CA2642239A1 (en) *	2006-02-16	2007-08-23	Boehringer Ingelheim International Gmbh	Drug combinations for the treatment of respiratory tract diseases
WO2008017637A1 (en)	2006-08-07	2008-02-14	Boehringer Ingelheim International Gmbh	Drug combinations for the treatment of respiratory tract diseases
UY30543A1 (en) *	2006-08-18	2008-03-31	Boehringer Ingelheim Int	AEROSOL FORMULATION FOR INHALATION OF BETA- AGONISTS
UY30542A1 (en) *	2006-08-18	2008-03-31	Boehringer Ingelheim Int	AEROSOL FORMULATION FOR INHALATION OF BETA AGONISTS
US20100099651A1 (en) *	2006-10-26	2010-04-22	Boehringer Ingelheim International Gmbh	Pharmaceutical compositions for treatment of respiratory and gastrointestinal disorders
EP1921070A1 (en)	2006-11-10	2008-05-14	Boehringer Ingelheim Pharma GmbH & Co. KG	Bicyclic heterocycles, medicaments comprising them, their use and process for their preparation
BRPI0907916A2 (en)	2008-02-07	2015-07-28	Boehringer Ingelheim Int	Spirocycle heterocycles, medicaments containing such compounds, and processes for preparing them
US8648191B2 (en)	2008-08-08	2014-02-11	Boehringer Ingelheim International Gmbh	Cyclohexyloxy substituted heterocycles, pharmaceutical compositions containing these compounds and processes for preparing them
WO2010060875A1 (en) *	2008-11-27	2010-06-03	Boehringer Ingelheim International Gmbh	Novel powdered crystalline medicines for inhalation
WO2014016548A2 (en)	2012-07-27	2014-01-30	Cipla Limited	Pharmaceutical composition
EP2906218B1 (en)	2012-10-09	2016-12-14	Boehringer Ingelheim International GmbH	Beta-2-adrenoceptor agonist for the treatment of cough

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4460581A (en) *	1982-10-12	1984-07-17	Boehringer Ingelheim Kg	(1-Hydroxy-2-amino-alkyl)-substituted benzoxazinones and benzoxazolinones
US4570630A (en)	1983-08-03	1986-02-18	Miles Laboratories, Inc.	Medicament inhalation device
FR2585563B1 (en)	1985-07-30	1993-11-12	Glaxo Group Ltd	DEVICE FOR ADMINISTERING MEDICINES TO PATIENTS
SE453566B (en)	1986-03-07	1988-02-15	Draco Ab	POWDER INHALATOR DEVICE
SG45171A1 (en)	1990-03-21	1998-01-16	Boehringer Ingelheim Int	Atomising devices and methods
DE4318455A1 (en)	1993-06-03	1994-12-08	Boehringer Ingelheim Kg	Capsule holder
DE19536902A1 (en)	1995-10-04	1997-04-10	Boehringer Ingelheim Int	Miniature fluid pressure generating device
AU5629301A (en) *	2000-04-27	2001-11-12	Boehringer Ingelheim Pharma Gmbh & Co. Kg	Novel, slow-acting betamimetics, a method for their production and their use as medicaments
IL155335A0 (en)	2000-10-12	2003-11-23	Boehringer Ingelheim Pharma	Crystalline monohydrate, method for producing the same and the use thereof in the production of a medicament
KR100971616B1 (en)	2001-06-22	2010-07-22	베링거 잉겔하임 파르마 게엠베하 운트 코 카게	Crystalline anticholinergic method for its production and pharmaceutical composition comprising the same
DE10130371A1 (en) *	2001-06-23	2003-01-02	Boehringer Ingelheim Pharma	New drug compositions based on anticholinergics, corticosteroids and betamimetics
ES2203327B1 (en) *	2002-06-21	2005-06-16	Almirall Prodesfarma, S.A.	NEW QUINUCLIDINE CARBAMATES AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM.
DE10230751A1 (en) *	2002-07-09	2004-01-22	Boehringer Ingelheim Pharma Gmbh & Co. Kg	New drug compositions based on new anticholinergics and EGFR kinase inhibitors
DE10246374A1 (en) *	2002-10-04	2004-04-15	Boehringer Ingelheim Pharma Gmbh & Co. Kg	New 4-(2-alkylamino-1-hydroxyethyl)-3-alkoxy-benzene-1,2-diol derivatives, are beta-mimetics having a long duration of action, useful e.g. for treating asthma, chronic obstructive pulmonary disease or arrhythmia
DE10253282A1 (en) *	2002-11-15	2004-05-27	Boehringer Ingelheim Pharma Gmbh & Co. Kg	Treatment of chronic obstructive pulmonary disease, using new or known N-substituted 2-amino-1-(benz-(1,4)-oxazin-3-on-8-yl)-ethanol derivative beta-mimetic agents, suitable for once-daily administration

2005
- 2005-04-18 PL PL11187038T patent/PL2422786T3/en unknown
- 2005-04-18 DK DK11187038.2T patent/DK2422786T3/en active
- 2005-04-18 EP EP05739576A patent/EP1781298B1/en not_active Expired - Lifetime
- 2005-04-18 KR KR1020137011141A patent/KR20130049840A/en not_active Ceased
- 2005-04-18 NZ NZ550797A patent/NZ550797A/en not_active IP Right Cessation
- 2005-04-18 ES ES11187038.2T patent/ES2523518T3/en not_active Expired - Lifetime
- 2005-04-18 EP EP11187038.2A patent/EP2422786B1/en not_active Expired - Lifetime
- 2005-04-18 JP JP2007508805A patent/JP2007533683A/en active Pending
- 2005-04-18 PT PT05739576T patent/PT1781298E/en unknown
- 2005-04-18 AU AU2005235419A patent/AU2005235419B2/en active Active
- 2005-04-18 SI SI200531904T patent/SI2422786T1/en unknown
- 2005-04-18 EA EA200601846A patent/EA013157B1/en active Protection Beyond IP Right Term
- 2005-04-18 DK DK05739576.6T patent/DK1781298T3/en active
- 2005-04-18 SG SG200902525-5A patent/SG152237A1/en unknown
- 2005-04-18 ES ES05739576T patent/ES2380370T3/en not_active Expired - Lifetime
- 2005-04-18 PL PL05739576T patent/PL1781298T4/en unknown
- 2005-04-18 AT AT05739576T patent/ATE539754T1/en active
- 2005-04-18 BR BRPI0510080A patent/BRPI0510080B8/en active IP Right Grant
- 2005-04-18 PT PT111870382T patent/PT2422786E/en unknown
- 2005-04-18 SI SI200531488T patent/SI1781298T1/en unknown
- 2005-04-18 WO PCT/EP2005/004073 patent/WO2005102349A1/en not_active Ceased
- 2005-04-18 CA CA2559699A patent/CA2559699C/en not_active Expired - Fee Related
- 2005-04-18 KR KR1020067024528A patent/KR101287460B1/en not_active Expired - Lifetime
- 2005-04-19 UY UY28861A patent/UY28861A1/en not_active Application Discontinuation
- 2005-04-20 PE PE2005000432A patent/PE20060462A1/en active IP Right Grant
- 2005-04-20 MY MYPI20051739A patent/MY148945A/en unknown
- 2005-04-21 TW TW101108945A patent/TWI374739B/en not_active IP Right Cessation
- 2005-04-21 TW TW094112735A patent/TWI372056B/en active
- 2005-04-22 AR ARP050101601A patent/AR049262A1/en not_active Application Discontinuation
2006
- 2006-08-08 ZA ZA2006/06624A patent/ZA200606624B/en unknown
- 2006-08-24 IL IL177685A patent/IL177685A/en active IP Right Grant
- 2006-10-23 EC EC2006006947A patent/ECSP066947A/en unknown
- 2006-11-02 NO NO20065060A patent/NO337714B1/en active Protection Beyond IP Right Term
2012
- 2012-03-26 CY CY20121100308T patent/CY1113890T1/en unknown
2013
- 2013-05-26 IL IL226562A patent/IL226562A0/en unknown
2014
- 2014-11-07 CY CY20141100925T patent/CY1115719T1/en unknown
2015
- 2015-12-01 LT LTPA2015043C patent/LTC1781298I2/en unknown
- 2015-12-01 HU HUS1500058C patent/HUS1500058I1/en unknown
- 2015-12-01 BE BE2015C065C patent/BE2015C065I2/fr unknown
- 2015-12-01 NL NL300779C patent/NL300779I2/en unknown
2016
- 2016-05-09 LU LU93066C patent/LU93066I2/en unknown
- 2016-06-22 FR FR16C0029C patent/FR16C0029I2/en active Active
- 2016-12-01 NO NO2016022C patent/NO2016022I1/en unknown
2017
- 2017-01-13 FI FIC20170005C patent/FIC20170005I1/en unknown
- 2017-04-20 CY CY2017014C patent/CY2017014I1/en unknown

Also Published As

Publication number	Publication date
PE20060462A1 (en)	2006-06-19
EP2422786A1 (en)	2012-02-29
TWI372056B (en)	2012-09-11
NL300779I2 (en)	2017-11-02
CA2559699A1 (en)	2005-11-03
AR049262A1 (en)	2006-07-12
PL1781298T3 (en)	2012-06-29
WO2005102349A1 (en)	2005-11-03
DK2422786T3 (en)	2014-11-17
AU2005235419A1 (en)	2005-11-03
CY2017014I2 (en)	2017-11-14
ES2523518T3 (en)	2014-11-26
TW201231055A (en)	2012-08-01
IL177685A (en)	2013-10-31
AU2005235419B2 (en)	2010-11-04
EA013157B1 (en)	2010-02-26
EP1781298B1 (en)	2012-01-04
NZ550797A (en)	2010-08-27
CY2017014I1 (en)	2017-11-14
MY148945A (en)	2013-06-14
PL1781298T4 (en)	2017-07-31
KR101287460B1 (en)	2013-07-23
TWI374739B (en)	2012-10-21
ES2380370T3 (en)	2012-05-11
KR20130049840A (en)	2013-05-14
NO2016022I2 (en)	2016-12-01
LU93066I2 (en)	2016-07-11
NO2016022I1 (en)	2016-12-01
KR20070015592A (en)	2007-02-05
CY1115719T1 (en)	2017-01-25
SG152237A1 (en)	2009-05-29
ATE539754T1 (en)	2012-01-15
EA200601846A1 (en)	2007-04-27
LTC1781298I2 (en)	2018-09-25
IL177685A0 (en)	2006-12-31
PT2422786E (en)	2014-11-12
IL226562A0 (en)	2013-06-27
ECSP066947A (en)	2007-01-26
UY28861A1 (en)	2005-11-30
CY1113890T1 (en)	2016-07-27
SI2422786T1 (en)	2014-12-31
FIC20170005I1 (en)	2017-01-13
EP1781298A1 (en)	2007-05-09
BE2015C065I2 (en)	2024-08-08
ZA200606624B (en)	2008-01-08
NO337714B1 (en)	2016-06-06
EP2422786B1 (en)	2014-08-13
SI1781298T1 (en)	2012-04-30
NO20065060L (en)	2006-11-21
JP2007533683A (en)	2007-11-22
FR16C0029I2 (en)	2017-01-27
DK1781298T3 (en)	2012-05-07
PT1781298E (en)	2012-02-03
BRPI0510080B8 (en)	2021-05-25
PL2422786T3 (en)	2015-02-27
BRPI0510080B1 (en)	2020-08-18
CA2559699C (en)	2012-06-19
BRPI0510080A (en)	2007-10-16
HUS1500058I1 (en)	2016-01-28

Publication	Publication Date	Title
FR19C1031I1 (en)	2019-06-28
JP2005050342A5 (en)	2005-08-04
JP2005335822A5 (en)	2006-02-16
JP2005215570A5 (en)	2007-04-05
JP2005090513A5 (en)	2007-11-01
BE2015C065I2 (en)	2024-08-08
JP2005283165A5 (en)	2006-01-12
JP2005312547A5 (en)	2006-03-09
JP2005296230A5 (en)	2007-05-17
ECSDI055778S (en)	2005-08-11
JP2005245047A5 (en)	2007-03-22
JP2005266309A5 (en)	2007-06-07
JP2005208039A5 (en)	2005-10-27
JP2005295658A5 (en)	2006-07-06
DE602004032391D1 (en)	2011-06-01
JP2005229561A5 (en)	2008-12-04
JP2005226807A5 (en)	2006-10-19
JP2005221998A5 (en)	2006-09-28
JP2005214373A5 (en)	2006-09-28
JP2005217980A5 (en)	2006-06-15
JP2005265035A5 (en)	2007-04-19
JP2005104725A5 (en)	2007-01-25
JP2005257493A5 (en)	2005-11-04
JP2005264861A5 (en)	2007-01-11
IN2005CH01296A (en)	2007-08-03